Gelstat Stock

Gelstat FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Gelstat (GSAC) as of Sep 8, 2026 is 19.23 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 15.33 % — a change of 25.48% (higher).

FCF Conversion

19.23 %

YoY

25.48%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Gelstat is 2026 19.23 % . FCF Conversion Rate (FCF/EBITDA) of Gelstat was 2025 15.33 % . It decreases by 25.48% higher compared to the previous year.

The Gelstat FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
3,111.66 USD
Jan 1, 2019
-98.29 USD
Jan 1, 2020
47.92 USD
Jan 1, 2021
43.13 USD
Jan 1, 2022
22.65 USD
Jan 1, 2023
50.59 USD
Jan 1, 2024
15.33 USD
Jan 1, 2025
19.23 USD
The Gelstat FCF Conversion history
YEARFCF ConversionYoY
19.23 %+25.48%
15.33 %-69.70%
50.59 %+123.33%
22.65 %-47.48%
43.13 %-10.00%
47.92 %-148.76%
-98.29 %-103.16%
3,111.66 %+16,470.89%
18.78 %
Access this data via the Eulerpool API

Gelstat Stock analysis

What does Gelstat do? The Gelstat Corporation is a US-American company specializing in the production of pharmaceuticals and complementary preparations. The development and marketing of products that improve well-being and health is at the center of the company's business model. The Gelstat Corporation was founded in 2004 by Dr. Thomas Smith and Dr. David Knopman. Originally, the company focused on the development of methods for the diagnosis of degenerative brain diseases. In collaboration with renowned research institutions and universities, the Gelstat Corporation was able to achieve valuable achievements in this field. In 2008, the company expanded its portfolio and began producing medications and dietary supplements. The Gelstat Corporation focused particularly on the use of ingredients that have positive effects on the body and well-being according to scientific studies. Currently, the company is divided into two main divisions: Gelstat Migraine and Gelstat Sleep. Gelstat Migraine is an over-the-counter preparation used for pain relief in migraine attacks. The product contains a high concentration of magnesium and therefore does not cause side effects such as nausea or dizziness that can occur with many other pain relievers. The use of Gelstat Migraine in combination with other medications is also safe. Gelstat Sleep is a dietary supplement taken to improve sleep quality. It contains a combination of plant-based ingredients such as valerian, passionflower, and melatonin. These active ingredients have a calming effect and can help to fall asleep and stay asleep more quickly. Gelstat Sleep is free of chemical substances and therefore suitable for long-term use. In addition to the two main divisions, Gelstat Corporation also offers other products based on natural ingredients. These include dietary supplements to strengthen the immune system, products for joint discomfort, and for improving memory performance. The goal of Gelstat Corporation is to promote the health and well-being of people in a natural way. The company ensures that all production steps are carried out under strict quality controls. The product development is also based on scientific studies and done in close collaboration with experts in the respective field. In summary, the Gelstat Corporation is an innovative company specializing in the production of pharmaceuticals and complementary preparations. The company's products are based on natural ingredients and have positive effects on the well-being and health of people. Through close collaboration with experts and strict adherence to quality standards, Gelstat Corporation has quickly made a name for itself in the industry. Gelstat is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gelstat stock

FCF Conversion Rate (FCF/EBITDA) of Gelstat is 19.23 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Gelstat changed from 15.33 % to 19.23 %, representing a 25.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Gelstat since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Gelstat with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Gelstat

All Key Metrics — Gelstat